Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...
From wearable glucose monitors to AI-driven health insights, recent advances are giving patients new ways to manage blood ...
The U.S. Treasury Department said on Thursday that New York-based insurer MetLife's unit, American Life Insurance Company, ...
Traditionally, scientists believed that obesity led to type 2 diabetes by impairing insulin signaling within liver and fat ...
We need a health system that not only provides medication but also encourages a healthy lifestyle. Group empowerment, digital ...
The decision by Novo Nordisk to discontinue the insulin pens will force patients to revert to syringes, complicating diabetes care for millions of people.
Travel + Leisure on MSN22h
I’ve Traveled to 39 Countries With Type 1 Diabetes — Here's What It's LikeKrista Llewellyn was diagnosed with Type 1 diabetes at 12 years old, but she hasn’t let managing her blood sugar levels stop ...
Novo Nordisk is ceasing production of human insulin pens, focusing on newer obesity and diabetes injections. This shift has ...
Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. Read more.
On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.
Novo Nordisk said Thursday that it plans to eventually halt all of its human insulin pen production globally, ...
The University of Pittsburgh is studying ways to improve the lives of Type 2 diabetics, or people who just want to control ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback